PFE News Explorer

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear off.

Investors are "spooked" by plan to name a vaccine-sceptic as US health secretary, analysts say.

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear off.

President-elect Donald Trump taps Robert F. Kennedy Jr. to lead U.S. Health and Human Services Department (HHS). Vaccine stocks slide on the news.

Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.

The news outlet is pushing the Commission to release text messages between the E.U.’s top official and Pfizer as they negotiated a vaccine contract.

Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight on many fronts.

Deal-making has slowed in recent years, largely due to high interest rates, soaring company valuations and a tight regulatory environment.

The Kennedy scion has long been a skeptic of vaccines, pesticides and more. Corporate leaders worry he may gain policy power if Donald Trump wins.

A torrent of falsehoods, from home and abroad, have undermined what was once a shared faith in the honesty of America’s democracy.

The case to own big food stocks isn't great.

Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.

Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.

Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.

Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.

Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.

International health experts have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently.

GLP-1 pills are the next frontier for the weight-loss market.

The telehealth world is entering a new phase of vertical integration in healthcare.

Pfizer is launching a new direct-to-consumer platform that it hopes will help patients get access to medicines faster.